Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma.

Giacalone NJ, Den RB, Eisenberg R, Chen H, Olson SJ, Massion PP, Carbone DP, Lu B.

Future Oncol. 2013 May;9(5):737-45. doi: 10.2217/fon.13.19.

PMID:
23647301
[PubMed - indexed for MEDLINE]
2.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
[PubMed - indexed for MEDLINE]
3.

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.

Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar B, Wainer Z, Brown T, Schneider-Kolsky M, Conron M, Wright G, Watkins DN.

Thorax. 2013 Dec;68(12):1095-104. doi: 10.1136/thoraxjnl-2012-203021. Epub 2013 Jul 22.

PMID:
23878161
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.

Izar B, Sequist L, Lee M, Muzikansky A, Heist R, Iafrate J, Dias-Santagata D, Mathisen D, Lanuti M.

Ann Thorac Surg. 2013 Sep;96(3):962-8. doi: 10.1016/j.athoracsur.2013.05.091. Epub 2013 Aug 8.

PMID:
23932319
[PubMed - indexed for MEDLINE]
5.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.

J Thorac Cardiovasc Surg. 2012 Oct;144(4):794-807. doi: 10.1016/j.jtcvs.2012.06.030. Epub 2012 Jul 18.

PMID:
22818121
[PubMed - indexed for MEDLINE]
6.

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH.

Cancer Res. 2006 Apr 15;66(8):4049-54.

PMID:
16618724
[PubMed - indexed for MEDLINE]
Free Article
7.

Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, Stocchi L, Mihaylova Z, Bellezza G, Del Sordo R, Daddi G, Crinò L, Tonato M.

J Thorac Oncol. 2008 Apr;3(4):365-73. doi: 10.1097/JTO.0b013e318168c7d0.

PMID:
18379354
[PubMed - indexed for MEDLINE]
8.

Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.

Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K.

Chest. 2011 Dec;140(6):1494-502. doi: 10.1378/chest.10-3279. Epub 2011 May 26.

PMID:
21622548
[PubMed - indexed for MEDLINE]
9.

Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.

Yang J, Liu H, Wang H, Sun Y.

Pathol Res Pract. 2013 Aug;209(8):490-4. doi: 10.1016/j.prp.2013.04.018. Epub 2013 Jun 6.

PMID:
23827213
[PubMed - indexed for MEDLINE]
10.

Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.

Benlloch S, Galbis-Caravajal JM, Alenda C, Peiró FM, Sanchez-Ronco M, Rodríguez-Paniagua JM, Baschwitz B, Rojas E, Massutí B.

Ann Oncol. 2009 Jan;20(1):91-7. doi: 10.1093/annonc/mdn538. Epub 2008 Jul 29.

PMID:
18664559
[PubMed - indexed for MEDLINE]
Free Article
11.

New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.

Melloni G, Gajate AM, Sestini S, Gallivanone F, Bandiera A, Landoni C, Muriana P, Gianolli L, Zannini P.

Eur J Surg Oncol. 2013 Nov;39(11):1254-61. doi: 10.1016/j.ejso.2013.07.092. Epub 2013 Aug 13.

PMID:
23948705
[PubMed - indexed for MEDLINE]
12.

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.

Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.

J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237.

PMID:
23287853
[PubMed - indexed for MEDLINE]
13.

EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.

Lee JS, Kim HR, Lee CY, Shin M, Shim HS.

Ann Surg Oncol. 2013 Sep;20(9):3015-22. doi: 10.1245/s10434-013-2937-2. Epub 2013 Mar 23.

PMID:
23525704
[PubMed - indexed for MEDLINE]
14.

Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer.

Yan D, Wei P, An G, Chen W.

J Cardiothorac Surg. 2013 Jun 10;8:149. doi: 10.1186/1749-8090-8-149.

PMID:
23759026
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, Seki H, Taki S, Tonami H, Yamamoto I.

J Nucl Med. 2002 Jan;43(1):39-45.

PMID:
11801701
[PubMed - indexed for MEDLINE]
Free Article
16.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
[PubMed - indexed for MEDLINE]
17.

Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.

Moretti L, Yu DS, Chen H, Carbone DP, Johnson DH, Keedy VL, Putnam JB Jr, Sandler AB, Shyr Y, Lu B.

Oncologist. 2009 Nov;14(11):1106-15. doi: 10.1634/theoncologist.2009-0130. Epub 2009 Nov 6.

PMID:
19897534
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

DNA methylation markers and early recurrence in stage I lung cancer.

Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG.

N Engl J Med. 2008 Mar 13;358(11):1118-28. doi: 10.1056/NEJMoa0706550.

PMID:
18337602
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.

Starnes SL, Pathrose P, Wang J, Succop P, Morris JC, Bridges J, Kupert EY, Anderson M.

Ann Thorac Surg. 2012 May;93(5):1606-12. doi: 10.1016/j.athoracsur.2012.01.048. Epub 2012 Mar 20.

PMID:
22440368
[PubMed - indexed for MEDLINE]
20.

LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.

Li J, Shi SB, Shi WL, Wang Y, Yu LC, Zhu LR, Ge LP.

Transl Res. 2014 Jan;163(1):27-35. doi: 10.1016/j.trsl.2013.09.010. Epub 2013 Oct 10.

PMID:
24120632
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk